Saturday, July 11, 2026

pharma · Acute Myeloid Leukemia

Hutchison MediPharma

Hutchison MediPharma drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Hong Kong, CN HQ
683 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hong Kong, CN
Employees
683
Programs
1
Drugs
1
Patents
0
Intelligence · Drug Pipeline

Hutchison MediPharma pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Hutchison MediPharma drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to Hutchison MediPharma in public FDA and regional records.